[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8202343A1 - Un procedimiento para preparar imidazo-piridinas - Google Patents

Un procedimiento para preparar imidazo-piridinas

Info

Publication number
ES8202343A1
ES8202343A1 ES500727A ES500727A ES8202343A1 ES 8202343 A1 ES8202343 A1 ES 8202343A1 ES 500727 A ES500727 A ES 500727A ES 500727 A ES500727 A ES 500727A ES 8202343 A1 ES8202343 A1 ES 8202343A1
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
preparation
pyridines
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500727A
Other languages
English (en)
Other versions
ES500727A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of ES500727A0 publication Critical patent/ES500727A0/es
Publication of ES8202343A1 publication Critical patent/ES8202343A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE IMIDAZOPIRIDINAS DE FORMULA (I) O (II), EN LAS QUE Q Y R2 SON HIDROGENO O ALQUILO INFERIOR; PY ES 4- O 3-PIRIDINILO SIN SUSTITUIR O SUSTITUIDO CON UNO O DOS RADICALES ALQUILO INFERIOR; Y R1 Y R3 UEDE SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UNA 2-R3NH-3-R1NH-5-PY-6-Q-PIRIDINA, EN LA QUE O BIEN R1 O R3 EW HIDROGENO, CON UBN ORTOALCANOATO INFERIOR DE TRIALQUILO INFERIOR, TENIENDO Q, PY Y, EN SU CASO, R1 O R3 LOS MISMOS SIGNIFICADOS QUE EN LAS FORMULAS (I) Y (II). LA REACCION SE LLEVA A CABO EN AUSENCIA O PRESENCIA DE UN DISOLVENTE INERTE A UNA TEMPERATURA COMPRENDIDA ENTRE 50 Y 150 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO AGENTES CARDIOTONICOS.
ES500727A 1980-03-28 1981-03-26 Un procedimiento para preparar imidazo-piridinas Expired ES8202343A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/135,211 US4276293A (en) 1980-03-28 1980-03-28 Compositions and their preparation

Publications (2)

Publication Number Publication Date
ES500727A0 ES500727A0 (es) 1982-01-16
ES8202343A1 true ES8202343A1 (es) 1982-01-16

Family

ID=22467044

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500727A Expired ES8202343A1 (es) 1980-03-28 1981-03-26 Un procedimiento para preparar imidazo-piridinas

Country Status (22)

Country Link
US (1) US4276293A (es)
JP (1) JPS56150090A (es)
KR (1) KR830005217A (es)
AU (1) AU6883781A (es)
BE (1) BE888088A (es)
CA (1) CA1159061A (es)
DE (1) DE3112197A1 (es)
DK (1) DK136881A (es)
ES (1) ES8202343A1 (es)
FI (1) FI810921L (es)
FR (1) FR2479225A1 (es)
GB (1) GB2072673B (es)
IL (1) IL62403A0 (es)
IT (1) IT1136972B (es)
LU (1) LU83259A1 (es)
NL (1) NL8101455A (es)
NO (1) NO811041L (es)
NZ (1) NZ196573A (es)
PH (1) PH16999A (es)
PT (1) PT72744B (es)
SE (1) SE8101951L (es)
ZA (1) ZA811776B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363911A (en) * 1981-09-03 1982-12-14 Sterling Drug Inc. 1,2-Dihydro-6-[2-(dimethylamino)ethenyl]-2-oxo-5-(pyridinyl) nicotinonitriles
US4465686A (en) * 1981-09-08 1984-08-14 Sterling Drug Inc. 5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation
US4347363A (en) * 1981-09-17 1982-08-31 Sterling Drug Inc. Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles
US4599423A (en) * 1982-04-26 1986-07-08 Sterling Drug Inc. Preparation of 5-(hydroxy- and/or aminophenyl-6-lower-alkyl)-2(1H)-pyridinones
NO163008C (no) * 1982-05-24 1990-03-21 Sterling Drug Inc 2-(laverealkoksy)-1-(pyridinyl)etenyl-lavere-alkylketon og fremgangsmaate for fremstilling av pyridinylnikotinderivater.
US4469871A (en) * 1982-05-24 1984-09-04 Sterling Drug Inc. Process for preparing 2-(lower-alkoxy)-1-(pyridinyl) ethenyl lower-alkyl ketones
US4417054A (en) * 1982-05-24 1983-11-22 Sterling Drug Inc. 2-(Lower-alkoxy)-1-(pyridinyl)ethenyl lower-alkyl ketones
US4413127A (en) * 1982-05-24 1983-11-01 Sterling Drug Inc. Preparation of 1,2-dihydro-6-(lower alkyl)-2-oxo-5-(pyridinyl)nicotinonitriles
US4469699A (en) * 1982-08-25 1984-09-04 Sterling Drug Inc. 5-(4-Thiazolyl)-6-alkyl-2(1H)-pyridinones and their cardiotonic use
US4539327A (en) * 1982-08-25 1985-09-03 Sterling Drug Inc. 5-(2-Substituted-4-thiazolyl)-6-alkyl-2(1H)-pyridinones and cardiotonic use thereof
US4595762A (en) * 1982-08-25 1986-06-17 Sterling Drug Inc. 5-α-bromoalkanoyl-2-oxo-3-pyridinecarbonitriles
US4448780A (en) * 1982-09-03 1984-05-15 Sterling Drug Inc. N-(Lower-alkyl)-N'-[5-(pyridinyl)-2-pyridinyl]ureas and cardiotonic use thereof
US4517192A (en) * 1983-01-31 1985-05-14 Sterling Drug Inc. 6-Alkyl-5-[4-(alkylsulfinyl or alkylsulfonyl)phenyl]-2(1H)-pyridinones and their use as cardiatonics
US4977144A (en) * 1988-08-02 1990-12-11 Ciba-Geigy Corporation Imidazo[4,5-b]pyridine derivatives as cardiovascular agents
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
US5010086A (en) * 1990-02-28 1991-04-23 Sterling Drug Inc. Imidazopyridines, compositions and use
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US20050112770A1 (en) 2002-02-14 2005-05-26 Fuji Photo Film Co., Ltd. Method for optical measurement of multi-stranded nucleic acid

Also Published As

Publication number Publication date
PH16999A (en) 1984-05-04
BE888088A (fr) 1981-09-24
NZ196573A (en) 1984-03-16
LU83259A1 (fr) 1981-10-29
FR2479225B1 (es) 1984-05-18
DK136881A (da) 1981-09-29
IL62403A0 (en) 1981-05-20
FR2479225A1 (fr) 1981-10-02
IT8120784A0 (it) 1981-03-27
NL8101455A (nl) 1981-10-16
PT72744A (en) 1981-04-01
SE8101951L (sv) 1981-09-29
DE3112197A1 (de) 1982-02-25
GB2072673B (en) 1983-11-02
IT1136972B (it) 1986-09-03
ES500727A0 (es) 1982-01-16
PT72744B (en) 1982-03-24
FI810921L (fi) 1981-09-29
AU6883781A (en) 1981-10-08
CA1159061A (en) 1983-12-20
NO811041L (no) 1981-09-28
GB2072673A (en) 1981-10-07
JPS56150090A (en) 1981-11-20
KR830005217A (ko) 1983-08-03
US4276293A (en) 1981-06-30
ZA811776B (en) 1982-04-28

Similar Documents

Publication Publication Date Title
ES8202343A1 (es) Un procedimiento para preparar imidazo-piridinas
MD1761B2 (ro) Eteri de 2,6-dihidroxipiridină, procedeu de preparare a lor, compoziţie erbicidă şi metodă de combatere a creşterii plantelor indezirabile
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
ES8700661A1 (es) Un procedimiento para preparar derivados de pirimidina
ES8107215A1 (es) Un procedimiento para preparar una 2-r-6-py-3(2h)-piridaci- nona
ES8704492A1 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
ES8202339A1 (es) Un procedimiento para preparar una pirazolopiridina
ES8104186A1 (es) Un procedimiento para la preparacion de 9-aminoalquilfluore-no
ES8601138A1 (es) Un procedimiento para preparar derivados de 5-(piridinil o fenil)-2(1h)-piridinona
ES8202006A1 (es) Un procedimiento para preparar derivados de imidazo (4,5-b) piridina
ES8602764A1 (es) Un procedimiento para preparar derivados de tiadiazina
ES8306733A1 (es) Derivados de anilina y sus sales.
SE8107551L (sv) 1,2-dihydro-5-(pyridinyl)nikotinamidderivat och forfarande for framstellning derav
GB1474896A (en) Salts of phenylpyridazines and the preparation thereof
FR2529891B1 (es)
IE780982L (en) 4-hydroxythiazoline-2-thiones.
ES8403442A1 (es) Un procedimiento de preparacion de 1-2(arilmetil)aril-4-oxociclohexanol-oximas.
ES8400435A1 (es) Procedimiento para preparar 1,2-dihidropirido (3,4 6) pirazinas.
ES8506301A1 (es) Un procedimiento para preparar 2-alcoxi-5-(piridinil) piridinas
US4198500A (en) Trans-4,5-didehydro-PGI1 amides
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES481486A1 (es) Procedimientos para preparar derivados de acidos 1-pirrol- carboxilixos
BG60209B2 (bg) Метод за получаване на производни на дихидро- пиримидотиазин
GB1426666A (en) Pyridine derivatives their preparation and pharmaceutical composi ions containing them
GB1510075A (en) Acid addition salt of a substituted pyrido-dioxin derivative